# Biothea Pharma, Inc. — Form D

Biothea Pharma, Inc. of Boston, MA, a company, filed a Form D exempt-offering notice with the SEC on 2021-08-06. The offering totals $22.0M, of which $22.0M was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2021-08-06
- Form: D
- Accession: 0001567619-21-014627
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $22.0M
- Amount sold: $22.0M
- Investors: 30
- Date of first sale: 2021-07-23
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-409135

## Issuer

- Name: Biothea Pharma, Inc.
- CIK: 0001877163
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: 125 Summer Street, Boston, MA, 02110
- Phone: (857) 284-8876

## Officers, directors & promoters (7)

| Name | Role | Location |
| --- | --- | --- |
| Anthony J Aiudi | Director | Boston, MA |
| Torbjorn J Bjerke | Director | Boston, MA |
| Marina S Bozilenko | Director | Boston, MA |
| Jean-Pierre J Sommadossi, Ph.D. | Director | Boston, MA |
| Marina S Bozilenko | Executive Officer | Boston, MA |
| Andrea J Corcoran | Executive Officer | Boston, MA |
| Rohit J Mehta | Executive Officer | Boston, MA |

## More

- [CIK 1877163 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1877163&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001567619-21-014627.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.